Blog
RSS FeedPosted by Michael Wonder on 09 Sep 2025
Revisiting the FDA’s accelerated approval pathway
8 September 2025 - After aducanumab’s accelerated approval for Alzheimer's disease, and prompted by long standing concerns regarding the accelerated approval pathway ...
Posted by Michael Wonder on 29 Aug 2025
UK Government, pharma industry fail to agree on medicines payment scheme
28 August 2025 - Negotiations between the UK Government and the pharmaceutical industry have ended without an agreement on changes ...
Posted by Michael Wonder on 11 Aug 2025
Trump’s trade war is not the only threat to cheap PBS medicines
10 August 2025 - Australia’s health system is rightly celebrated for its universal access and cost effectiveness, but its outdated assessment ...
Posted by Michael Wonder on 10 Aug 2025
America’s drug regulator is in turmoil
10 August 2025 - The already fraught oversight of rare disease treatments is becoming politicised. ...
Posted by Michael Wonder on 09 Aug 2025
Labor ‘very concerned’ by Trump pharma threat
7 August 2025 - The Albanese Government says it is “very concerned” after Donald Trump’s latest tariff threat on a key ...
Posted by Michael Wonder on 09 Aug 2025
Labor vows to ‘fight’ as Trump threatens pharma tariffs
8 August 2025 - The Albanese government is vowing to “fight for the PBS” as Donald Trump tries to strong-arm ...
Posted by Michael Wonder on 06 Aug 2025
How Australia is getting tangled in Trump’s fight with big pharma
6 August 2025 - The US president is angry Americans pay more for their medicines. Will he want the PBS – ...
Posted by Michael Wonder on 04 Aug 2025
Why drug prices for some big medicines will remain high for a longer time
3 August 2025 - Little known provisions in the Big Beautiful Bill lobbied by industry will cost Medicare billions in missed ...
Posted by Michael Wonder on 01 Aug 2025
FDA approves Alhemo as once daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with haemophilia A or B without inhibitors
31 July 2025 - FDA approval is based on phase 3 trial data (explorer8), which established the safety and efficacy of ...
Posted by Michael Wonder on 01 Aug 2025
Trump takes aim at ‘foreign freeloading nations’ over drug prices in new threat to PBS
1 August 2025 - US President Donald Trump has blamed “foreign freeloading nations” for the high drug prices faced by ...
Posted by Michael Wonder on 26 Jul 2025
Australia’s PBS must ‘absolutely’ be protected in trade talks, says Make America Healthy Again medical adviser Aseem Malhotra
26 July 2025 - The chief medical adviser to Make America Healthy Again campaign has defended Australia’s PBS, as the Trump ...
Posted by Michael Wonder on 17 Jul 2025
Pfizer broadside on PBS productivity amid pharma tariff fears
16 July 2025 - Multinational conglomerate Pfizer has accused the PBS of “undervaluing” medical products in a submission to the ...
Posted by Michael Wonder on 17 Jul 2025
Labor and Coalition in lockstep as Trump threatens to pull pharma tariffs forward
16 July 2025 - US President Donald Trump’s threat to bring forward planned tariffs of up to 200% on pharmaceuticals ...
Posted by Michael Wonder on 16 Jul 2025
FDA embraces radical transparency by publishing complete response letters
10 July 2025 - The US FDA today published more than 200 decision letters, known as complete response letters. ...
Posted by Michael Wonder on 18 Jun 2025
FDA to issue new Commissioner’s national priority vouchers to companies supporting US national interests
17 June 2025 - The US FDA today announced its Commissioner’s National Priority Voucher program to enhance the health interests of ...